[HTML][HTML] Thrombotic microangiopathy and the kidney

V Brocklebank, KM Wood… - Clinical Journal of the …, 2018 - journals.lww.com
Thrombotic microangiopathy can manifest in a diverse range of diseases and is characterized
by thrombocytopenia, microangiopathic hemolytic anemia, and organ injury, including AKI…

Hemolytic uremic syndrome in pregnancy and postpartum

…, E Bresin, F Provôt, V Brocklebank… - Clinical Journal of the …, 2017 - journals.lww.com
Background Pregnancy is associated with various forms of thrombotic microangiopathy,
including hemolytic uremic syndrome. A previous small French study suggested that pregnancy-…

Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2

…, SC Lovell, VG Shuttleworth, V Brocklebank… - Science …, 2019 - science.org
Excessive type I interferon (IFNα/β) activity is implicated in a spectrum of human disease, yet
its direct role remains to be conclusively proven. We investigated two siblings with severe …

[HTML][HTML] Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland

V Brocklebank, S Johnson, TP Sheerin, SD Marks… - Kidney international, 2017 - Elsevier
Factor H autoantibodies can impair complement regulation, resulting in atypical hemolytic
uremic syndrome, predominantly in childhood. There are no trials investigating treatment, and …

Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea

V Brocklebank, D Kavanagh - Clinical kidney journal, 2017 - academic.oup.com
Thrombotic microangiopathy (TMA), characterized by organ injury occurring consequent to
severe endothelial damage, can manifest in a diverse range of diseases. In complement-…

[HTML][HTML] Thrombotic microangiopathy in inverted formin 2–mediated renal disease

…, M Wetherall, G Salkus, V Brocklebank… - Journal of the …, 2017 - journals.lww.com
The demonstration of impaired C regulation in the thrombotic microangiopathy (TMA)
atypical hemolytic uremic syndrome (aHUS) resulted in the successful introduction of the C …

[HTML][HTML] Long-term outcomes and response to treatment in diacylglycerol kinase epsilon nephropathy

V Brocklebank, G Kumar, AJ Howie, J Chandar… - Kidney international, 2020 - Elsevier
… Author links open overlay panel Vicky Brocklebank 1 2 , Gurinder Kumar 3 , Alexander J.
Howie 4 , Jayanthi Chandar 5 , David V. Milford 4 , Janet Craze 6 , Jonathan Evans 7 , Eric …

[HTML][HTML] A De Novo Deletion in the Regulators of Complement Activation Cluster Producing a Hybrid Complement Factor H/Complement Factor H–Related 3 Gene in …

…, M Waldron, V Wilson, V Brocklebank… - Journal of the …, 2016 - journals.lww.com
The regulators of complement activation cluster at chromosome 1q32 contains the complement
factor H (CFH) and five complement factor H–related (CFHR) genes. This area of the …

[HTML][HTML] Assessing the impact of prophylactic eculizumab on renal graft survival in atypical hemolytic uremic syndrome

EK Glover, K Smith-Jackson, V Brocklebank… - …, 2023 - journals.lww.com
EKG wrote the article and contributed to data collection and analysis. KSJ contributed to the
drafting of the article and data collection. VB contributed to the drafting of the article and data …

[HTML][HTML] Functional characterization of rare genetic variants in the N-terminus of complement factor H in aHUS, C3G, and AMD

EKS Wong, TM Hallam, V Brocklebank… - Frontiers in …, 2021 - frontiersin.org
Membranoproliferative glomerulonephritis (MPGN), C3 glomerulopathy (C3G), atypical
haemolytic uraemic syndrome (aHUS) and age-related macular degeneration (AMD) have all …